Breaking News Instant updates and real-time market news.

ALDX

Aldeyra

$7.47 /

+0.69 (+10.18%)

07:14
08/06/20
08/06
07:14
08/06/20
07:14

Aldeyra reports Q2 EPS (25c), consensus (34c)

Based on current operating plans, cash, cash equivalents, and marketable securities as of June 30, 2020, plus the additional at-the-market offering program proceeds, are expected to be sufficient to fund operations through the end of 2022, including potential NDA approvals for reproxalap in dry eye disease and allergic conjunctivitis, assuming positive clinical trial results, and planned NDA submissions, acceptances, and approvals. Use of Aldeyra's cash, cash equivalents, and marketable securities are also expected to include the continuation of Part 1 of the Phase 3 GUARD Trial in PVR, and Phase 2 clinical testing of ADX-629, an orally administered RASP inhibitor, in inflammatory diseases.

  • 06

    Aug

  • 11

    Aug

ALDX Aldeyra
$7.47 /

+0.69 (+10.18%)

06/04/20 JonesTrading
Aldeyra pact with FDA may point to 'surer path' for approval, says JonesTrading
05/11/20 Oppenheimer
Aldeyra initiated with an Outperform at Oppenheimer
12/03/19 JonesTrading
Aldeyra dry eye data positive nearly across the board, says JonesTrading
10/22/19 Cantor Fitzgerald
Aldeyra assumed with an Overweight at Cantor Fitzgerald

TODAY'S FREE FLY STORIES

Initiation
Terreno Realty initiated with a Neutral at Goldman Sachs » 05:02
09/29/20
09/29
05:02
09/29/20
05:02
TRNO

Terreno Realty

$55.60 /

+1.335 (+2.46%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRNO Terreno Realty
$55.60 /

+1.335 (+2.46%)

TRNO Terreno Realty
$55.60 /

+1.335 (+2.46%)

09/22/20 Baird
Terreno Realty upgraded to Outperform from Neutral at Baird
07/22/20
Fly Intel: Top five analyst initiations
07/22/20 Scotiabank
Scotiabank starts Terreno Realty at Outperform with $60 price target
07/21/20 Scotiabank
Terreno Realty initiated with an Outperform at Scotiabank
Initiation
Duke Realty resumed with a Neutral at Goldman Sachs » 05:02
09/29/20
09/29
05:02
09/29/20
05:02
DRE

Duke Realty

$36.92 /

+0.7 (+1.93%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRE Duke Realty
$36.92 /

+0.7 (+1.93%)

DRE Duke Realty
$36.92 /

+0.7 (+1.93%)

08/24/20 Truist
Truist raises price targets on select REITs
08/04/20 Mizuho
Duke Realty price target raised to $43 from $40 at Mizuho
06/19/20 Stifel
Rexford Industrial added to Select List at Stifel
05/20/20 BofA
Duke Realty upgraded to Buy from Neutral at BofA
DRE Duke Realty
$36.92 /

+0.7 (+1.93%)

Initiation
First Industrial Realty resumed with a Sell at Goldman Sachs » 05:01
09/29/20
09/29
05:01
09/29/20
05:01
FR

First Industrial Realty

$40.78 /

+1.03 (+2.59%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FR First Industrial Realty
$40.78 /

+1.03 (+2.59%)

FR First Industrial Realty
$40.78 /

+1.03 (+2.59%)

08/04/20 Mizuho
First Industrial Realty price target raised to $47 from $45 at Mizuho
07/24/20 Baird
First Industrial Realty upgraded to Outperform from Neutral at Baird
03/27/20
Fly Intel: Top five analyst initiations
03/27/20 RBC Capital
First Industrial Realty initiated with an Outperform at RBC Capital
FR First Industrial Realty
$40.78 /

+1.03 (+2.59%)

Initiation
Prologis resumed with a Buy at Goldman Sachs » 04:59
09/29/20
09/29
04:59
09/29/20
04:59
PLD

Prologis

$100.01 /

+2.37 (+2.43%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLD Prologis
$100.01 /

+2.37 (+2.43%)

PLD Prologis
$100.01 /

+2.37 (+2.43%)

08/24/20 Evercore ISI
Prologis downgraded to In Line from Outperform at Evercore ISI
08/06/20 Deutsche Bank
Prologis price target raised to $121 from $90 at Deutsche Bank
07/28/20 Wells Fargo
Prologis price target raised to $115 from $110 at Wells Fargo
07/22/20 BMO Capital
Prologis price target raised to $111 from $96 at BMO Capital
PLD Prologis
$100.01 /

+2.37 (+2.43%)

PLD Prologis
$100.01 /

+2.37 (+2.43%)

Upgrade
Hershey upgraded to Outperform from Market Perform at BMO Capital » 04:56
09/29/20
09/29
04:56
09/29/20
04:56
HSY

Hershey

$140.35 /

+0.85 (+0.61%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HSY Hershey
$140.35 /

+0.85 (+0.61%)

HSY Hershey
$140.35 /

+0.85 (+0.61%)

07/24/20 Evercore ISI
Hershey upgraded to Outperform from In Line at Evercore ISI
04/24/20
Fly Intel: Top five analyst downgrades
04/24/20 BMO Capital
Hershey price target lowered to $140 from $150 at BMO Capital
04/24/20 Piper Sandler
Hershey downgraded to Neutral from Overweight at Piper Sandler
HSY Hershey
$140.35 /

+0.85 (+0.61%)

HSY Hershey
$140.35 /

+0.85 (+0.61%)

HSY Hershey
$140.35 /

+0.85 (+0.61%)

Conference/Events
Morgan Stanley strategists to hold analyst/industry conference call » 04:55
09/29/20
09/29
04:55
09/29/20
04:55

Asia and Emerging Markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

Conference/Events
Arvinas participates in a conference call with Cantor Fitzgerald » 04:55
09/29/20
09/29
04:55
09/29/20
04:55
ARVN

Arvinas

$22.97 /

-1.42 (-5.82%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARVN Arvinas
$22.97 /

-1.42 (-5.82%)

ARVN Arvinas
$22.97 /

-1.42 (-5.82%)

06/01/20 Citi
Arvinas upgraded to Buy from Neutral at Citi
05/29/20 Roth Capital
Roth Capital recommends buying Arvinas on ASCO dip
05/29/20 Piper Sandler
Arvinas should be bought on weakness after ASCO update, says Piper Sandler
05/15/20 Roth Capital
Roth Capital maintains positive outlook on Arvinas after ASCO abstract review
ARVN Arvinas
$22.97 /

-1.42 (-5.82%)

  • 07
    Nov
ARVN Arvinas
$22.97 /

-1.42 (-5.82%)

Conference/Events
TC Energy management to meet virtually with JPMorgan » 04:55
09/29/20
09/29
04:55
09/29/20
04:55
TRP

TC Energy

$44.20 /

-0.39 (-0.87%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRP TC Energy
$44.20 /

-0.39 (-0.87%)

TRP TC Energy
$44.20 /

-0.39 (-0.87%)

08/06/20 BMO Capital
TC Energy price target raised to C$68 from C$65 at BMO Capital
07/15/20 Scotiabank
TC Energy upgraded to Outperform on recent selloff at Scotiabank
07/15/20 Scotiabank
TC Energy upgraded to Outperform from Sector Perform at Scotiabank
07/10/20 US Capital Advisors
TC Energy initiated with a Buy at US Capital Advisors
TRP TC Energy
$44.20 /

-0.39 (-0.87%)

General news
New York Federal Reserve Bank President John Williams Speech to be released at 09:15  04:55
09/29/20
09/29
04:55
09/29/20
04:55
 
General news
Week of 9/26 Redbook to be released at 08:55  04:55
09/29/20
09/29
04:55
09/29/20
04:55
 
Conference/Events
Morgan Stanley strategists to hold analyst/industry conference call » 04:55
09/29/20
09/29
04:55
09/29/20
04:55

Asia and Emerging Markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Masonite management to meet virtually with Benchmark » 04:55
09/29/20
09/29
04:55
09/29/20
04:55
DOOR

Masonite

$96.10 /

+4.15 (+4.51%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOOR Masonite
$96.10 /

+4.15 (+4.51%)

DOOR Masonite
$96.10 /

+4.15 (+4.51%)

09/24/20 JPMorgan
Jeld-Wen price hike also positive for Masonite, says JPMorgan
09/24/20 RBC Capital
Masonite price target raised to $116 from $111 at RBC Capital
09/16/20 Wedbush
Masonite price target raised to $103 from $97 at Wedbush
07/20/20
Fly Intel: Top five analyst downgrades
DOOR Masonite
$96.10 /

+4.15 (+4.51%)

General news
Federal Reserve Board of Governors Vice Chair Richard Clarida Speech to be released at 11:40  04:55
09/29/20
09/29
04:55
09/29/20
04:55
 
Conference/Events
Jefferies home services analysts hold an analyst/industry conference call » 04:55
09/29/20
09/29
04:55
09/29/20
04:55
IAC

IAC

$117.91 /

+2.57 (+2.23%)

, ANGI

Angi Homeservices

$10.55 /

+0.28 (+2.73%)

Analysts, along with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IAC IAC
$117.91 /

+2.57 (+2.23%)

ANGI Angi Homeservices
$10.55 /

+0.28 (+2.73%)

IAC IAC
$117.91 /

+2.57 (+2.23%)

09/24/20 Piper Sandler
IAC initiated with an Overweight at Piper Sandler
09/15/20 Jefferies
IAC's key segments saw sequential acceleration in August, says Jefferies
09/14/20 KeyBanc
IAC initiated with an Overweight at KeyBanc
09/14/20 KeyBanc
IAC initiated with an Overweight at KeyBanc
ANGI Angi Homeservices
$10.55 /

+0.28 (+2.73%)

09/24/20 Piper Sandler
Angi Homeservices initiated with a Neutral at Piper Sandler
09/15/20 Jefferies
IAC's key segments saw sequential acceleration in August, says Jefferies
09/14/20 KeyBanc
Angi Homeservices initiated with an Overweight at KeyBanc
09/14/20 KeyBanc
Angi Homeservices initiated with an Overweight at KeyBanc
IAC IAC
$117.91 /

+2.57 (+2.23%)

ANGI Angi Homeservices
$10.55 /

+0.28 (+2.73%)

IAC IAC
$117.91 /

+2.57 (+2.23%)

IAC IAC
$117.91 /

+2.57 (+2.23%)

ANGI Angi Homeservices
$10.55 /

+0.28 (+2.73%)

ANGI Angi Homeservices
$10.55 /

+0.28 (+2.73%)

Conference/Events
Jefferies technology analyst to hold an analyst/industry conference call » 04:55
09/29/20
09/29
04:55
09/29/20
04:55

Analysts, along with Marc…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 7 minutes

Get Free Trial

Conference/Events
UBS industrials/utilities analyst to hold analyst/industry conference call » 04:55
09/29/20
09/29
04:55
09/29/20
04:55
WKHS

Workhorse Group

$28.12 /

+3.27 (+13.16%)

Industrials &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WKHS Workhorse Group
$28.12 /

+3.27 (+13.16%)

WKHS Workhorse Group
$28.12 /

+3.27 (+13.16%)

09/18/20 Colliers
Lordstown's presentation raised Colliers' expectations for Workhorse valuation
09/17/20 Roth Capital
Roth raises Workhorse target to $33 after Lordstown's 'compelling' analyst day
09/03/20
Fly Intel: Top five analyst initiations
09/03/20 Oppenheimer
Oppenheimer bullish on Workhorse Group, initiates with an Outperform
WKHS Workhorse Group
$28.12 /

+3.27 (+13.16%)

WKHS Workhorse Group
$28.12 /

+3.27 (+13.16%)

WKHS Workhorse Group
$28.12 /

+3.27 (+13.16%)

WKHS Workhorse Group
$28.12 /

+3.27 (+13.16%)

Conference/Events
UBS energy analyst to hold an analyst/industry conference call » 04:55
09/29/20
09/29
04:55
09/29/20
04:55
ENLC

EnLink Midstream

$2.28 /

-0.09 (-3.81%)

Energy Analyst Gershuni…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENLC EnLink Midstream
$2.28 /

-0.09 (-3.81%)

ENLC EnLink Midstream
$2.28 /

-0.09 (-3.81%)

09/25/20 Morgan Stanley
EnLink Midstream initiated with an Underweight at Morgan Stanley
05/06/20 Mizuho
EnLink Midstream price target lowered to $2.50 from $7 at Mizuho
04/02/20 Credit Suisse
EnLink Midstream downgraded to Underperform from Neutral at Credit Suisse
03/24/20 Barclays
EnLink Midstream downgraded to Underweight from Equal Weight at Barclays
ENLC EnLink Midstream
$2.28 /

-0.09 (-3.81%)

ENLC EnLink Midstream
$2.28 /

-0.09 (-3.81%)

Conference/Events
Incyte and MorphoSys to hold a joint conference call » 04:55
09/29/20
09/29
04:55
09/29/20
04:55
MOR

MorphoSys

$31.57 /

+0.51 (+1.64%)

, INCY

Incyte

$90.45 /

+3.97 (+4.59%)

Incyte and MorphoSys hold…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
MOR MorphoSys
$31.57 /

+0.51 (+1.64%)

INCY Incyte
$90.45 /

+3.97 (+4.59%)

MOR MorphoSys
$31.57 /

+0.51 (+1.64%)

08/10/20 Citi
MorphoSys initiated with a Buy at Citi
08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
08/03/20 Piper Sandler
Monjuvi U.S. launch a solid long-term contributor for Incyte, says Piper Sandler
06/25/20 RBC Capital
MorphoSys downgraded to Sector Perform from Outperform at RBC Capital
INCY Incyte
$90.45 /

+3.97 (+4.59%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
08/05/20 Mizuho
Incyte price target raised to $95 from $79 at Mizuho
08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
INCY Incyte
$90.45 /

+3.97 (+4.59%)

MOR MorphoSys
$31.57 /

+0.51 (+1.64%)

INCY Incyte
$90.45 /

+3.97 (+4.59%)

INCY Incyte
$90.45 /

+3.97 (+4.59%)

Conference/Events
Cowen financial services analyst to hold an analyst/industry conference call » 04:55
09/29/20
09/29
04:55
09/29/20
04:55

Financial Services…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Forte Biosciences management to meet virtually with Truist » 04:55
09/29/20
09/29
04:55
09/29/20
04:55
FBRX

Forte Biosciences

$50.33 /

+1.39 (+2.84%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
FBRX Forte Biosciences
$50.33 /

+1.39 (+2.84%)

FBRX Forte Biosciences
$50.33 /

+1.39 (+2.84%)

09/24/20 Chardan
Forte Biosciences price target raised to $110 from $60 at Chardan
09/18/20 Chardan
Seres Therapeutics downgraded to Neutral from Buy at Chardan
09/10/20 Chardan
Forte Biosciences price target raised to $60 from $45 at Chardan
08/28/20 Chardan
Forte Biosciences upgraded to Buy from Neutral at Chardan
FBRX Forte Biosciences
$50.33 /

+1.39 (+2.84%)

FBRX Forte Biosciences
$50.33 /

+1.39 (+2.84%)

Conference/Events
DCP Midstream management to meet virtually with Truist » 04:55
09/29/20
09/29
04:55
09/29/20
04:55
DCP

DCP Midstream

$11.02 /

+0.625 (+6.02%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
DCP DCP Midstream
$11.02 /

+0.625 (+6.02%)

DCP DCP Midstream
$11.02 /

+0.625 (+6.02%)

08/10/20 Truist
DCP Midstream price target raised to $17 from $8 at Truist
07/13/20 UBS
DCP Midstream upgraded to Neutral from Sell at UBS
07/13/20 UBS
DCP Midstream upgraded to Neutral from Sell at UBS
06/23/20 Jefferies
DCP Midstream, Phillips 66 and Holly Energy Partners cut to Hold at Jefferies
DCP DCP Midstream
$11.02 /

+0.625 (+6.02%)

DCP DCP Midstream
$11.02 /

+0.625 (+6.02%)

General news
New York Federal Reserve Bank President John Williams Speech to be released at 13:00  04:55
09/29/20
09/29
04:55
09/29/20
04:55
 
General news
Philadelphia Federal Reserve Bank President Patrick Harker Speech to be released at 09:30  04:55
09/29/20
09/29
04:55
09/29/20
04:55
 
General news
Federal Reserve Board of Governors Vice-Chair for Supervision Randal Quarles Speech to be released at 13:00  04:55
09/29/20
09/29
04:55
09/29/20
04:55
 
Conference/Events
Jefferies technology analyst to hold an analyst/industry conference call » 04:55
09/29/20
09/29
04:55
09/29/20
04:55
WDAY

Workday

$220.28 /

+4.31 (+2.00%)

, ORCL

Oracle

$59.58 /

-0.22 (-0.37%)

Analysts, along with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WDAY Workday
$220.28 /

+4.31 (+2.00%)

ORCL Oracle
$59.58 /

-0.22 (-0.37%)

WDAY Workday
$220.28 /

+4.31 (+2.00%)

08/31/20 Citi
Workday price target raised to $218 from $173 at Citi
08/28/20 JPMorgan
Workday price target raised to $250 from $200 at JPMorgan
08/28/20 RBC Capital
Workday price target raised to $280 from $220 at RBC Capital
08/28/20 BMO Capital
Workday price target raised to $265 from $207 at BMO Capital
ORCL Oracle
$59.58 /

-0.22 (-0.37%)

09/22/20 Morgan Stanley
Morgan Stanley says hard to tell if TikTok deal true 'thesis-changer' for Oracle
09/21/20
Fly Intel: Top five analyst upgrades
09/21/20 William Blair
TikTok deal 'major coup' for Oracle, says William Blair
09/21/20 RBC Capital
Oracle upgraded to Outperform from Sector Perform at RBC Capital
WDAY Workday
$220.28 /

+4.31 (+2.00%)

ORCL Oracle
$59.58 /

-0.22 (-0.37%)

ORCL Oracle
$59.58 /

-0.22 (-0.37%)

WDAY Workday
$220.28 /

+4.31 (+2.00%)

ORCL Oracle
$59.58 /

-0.22 (-0.37%)

WDAY Workday
$220.28 /

+4.31 (+2.00%)

ORCL Oracle
$59.58 /

-0.22 (-0.37%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.